Hongzhong Li

8PUBLICATIONS
25CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersAutonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2026
Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8+ T cell surveillance in lung cancer.

|May 21, 2026
Macrophage ALDH2 drives immunotherapy resistance by silencing CXCL9 through metabolic-epigenetic crosstalk.

|Sep 01, 2025
AEBP1 drives fibroblast-mediated T cell dysfunction in tumors.

Xiaoyu Wang, Jie Li, Daqiang Song

|Jun 02, 2025
Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications.

|Nov 27, 2024
Blocking WNT7A Enhances MHC-I Antigen Presentation and Enhances the Effectiveness of Immune Checkpoint Blockade Therapy.

Jiazheng Sun, Pin Wang, Ziying Yi

|Dec 13, 2023
Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis.

Yuru Chen, Jiazheng Sun, Jiazhou Liu

Pageof 2

Frequent Collaborators

4 joint publications

Guosheng Ren

2 joint publications

Jing Huang

2 joint publications

Daqiang Song

1 joint publications

Long Meng